U.S. Markets close in 4 hrs 43 mins

HemaCare Corporation (HEMA)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
2.650.00 (0.00%)
As of 10:00AM EDT. Market open.
People also watch
  • Did anyone else see $HEMA report from http://thesubwaytrader.com/?s=HEMA ? It had some interesting information. To criticize the incompetent is easy;it is more difficult to criticize the competent. Day trading trading stocks.

    The Subway Trader: Trading Stocks and Making Money
    Stock alerts from the The Subway Trader. Stock trading, making money and always looking for the next big money maker.
  • HEMA is finally taking off. That a company which knows Hemacare well bought $2.5M worth of the stock for $3.44 a share when the stock was trading between $1 - $2 is very telling as to what the future holds for HEMA.
  • Received an alert this am about $HEMA from http://monstastocks.com/?s=HEMA, you may want to take a look. Investing making money. Waldrop's principle: the person not here is the one working on the problem.

    Monsta Stocks: Trading Stocks and Making Money
    Stock alerts from the Monsta Stocks. Stock trading, making money and always looking for the next big money maker.
  • I mentioned late last year that HEMA was poised to test resistance at $1. It took a bit of time and chopping around but here we are printing a high of $1.01 today. This resistance may take some time to break through but when we do, it will position this stock for future gains. HEMA has not closed above $1 since the stock was making its plunge downward in 2007. This is a historically significant level to break.
  • Did anyone else see $HEMA report from http://monstatrader.com/?s=HEMA ? It had some interesting information. Simon's law: everything put together sooner or later fall apart. Investing day trading.

    MonstaTrader: OTC, NYSE, NASDAQ Stock Alerts for all Traders
    Stock alerts, stock trading, making money, sharing knowledge and always looking for the next big money maker.
  • Short info for $HEMA on http://squeezereport.com/?s=HEMA

  • The earnings release today looked great. I would be surprised if we don't start testing some resistance levels. The company has shown enough growth in revenue and margins in the past 12 months for the stock to start making a move to levels north of $1.
  • Move up On Above Average Volume. Wow, good day...the deal could be in! Well, sounded good anyways, but hopefully an indicator of things to come. Time will tell.
  • Huge Block Trade!. Oh wait...4 shares....sorry, maybe a square since at most made up of four points. oh well. Waiting for the next wave of progress!
  • new blog post on HEMA. I wrote up a new blog post on HEMA. Nothing earth shattering, just updates since my last HEMA post in Aug 2015

    nonamestocks dot com
  • Hema's business outlook. Reading through the financial information released by the company, I get the impression that they operate in a very small market, at least at this point in time. Hema is well funded, has no working capital constraints, and yet is operating at a loss, despite revenues of almost $10 million in 2015. I made some calculations, and I estimate that they need to grow the business some 30%/50% to get to break-even.

    Some people here have talked with management, maybe can answer my question: is there a big enough market out there for Hema to grow and eventually be profitable? Is there any comparable competitor?
  • New buy recommendation on hema. found on nasdaqstocksrus dot com spells out a bullish scenario on hema- anticipate big things
  • Debt and Cash?. Any info on either?
  • Disappointing Day. Being short sighted, it was a disappointing day today; although, I guess one can say it is consistent with the "buy the rumor, sell the fact" trading approach one sees in stocks. Long-term still quite positive.
  • HEMA Signs Distribution Agreement with China-Based Partner. Article on Yahoo news. This is excellent news with extraordinarily high potential.

    HemaCare Corporation, (HEMA) a leader in cell and tissue collection, processing, and cell therapy solutions, has expanded its global capabilities through a strategic distribution agreement in China with Shanghai-based MT-Biological Science and Technology Co. Ltd. This partnership ensures researchers in China can access HemaCare’s human healthy and disease state cryopreserved hematopoietic cell products for their basic scientific and cell therapy research and development needs in a timely manner and with local region support.
  • big news today- a china agreement. read press release just out! This is huge! Annual meeting today and will be attending another conference in a few weeks. Company may start to release quarterly rev and earning reports. This management is strong and deep and hold a large amount of shares. Intention too grow and reward shareholders.
  • when you click their worldwide partner's. you will be impressed with their footprint via the world. Now with this China Agreement we should we

    a dramatic rev increase- remember there are 1.2 billion people in China. This i believe could be a game

    changer. Once the herd sees the potential i do believe that they will fall over one another to own a piece of

    this high growth niche player in the big pharma and biotech industrial space.
  • A breakout is getting closer. HEMA has been in a consolidation pattern since the move into the $0.70-$0.80 range and that pattern is nearing an end. Technically, the resolution to this current pattern strongly favors a breakout to the upside. If we get any fundamental news to help confirm this, I would expect a serious test of major resistance at $1 is coming soon. The longer term outlook, both from the fundamentals and technicals, looks extremely promising.
  • Tried to buy more HEMA today. Could not get filled at .705. I already have a very large position but thought I'd add to it. The stock seems to be building a solid base.
  • conversation with management. Had a 30 minute and very informative conversation that lead me to believe that hemacare is well position in their niche to supply big pharma and biotech companies with the needed blood components and stem cell and related product. There donor list is highly prized and with their new and expanding product catalog offers continued growth potential short and long term. Their main competitor Allcells located in San Fran- Management believes that they better equipped and they have noticed that customer's are moving over to Hemacare because of better customer service, better and more pure products and superior delivery.

    The company does have plans to become fully reporting again, but i believe that will not happen until the end of 2016.

    The growth has been excellent! During the past 3 years the company has shown 100% growth. They sold their

    blood bank business to the Red Cross and then kept their star employees and they were off too the races

    If you are looking for growth short,medium and long term Hemacare has the potential for attractive gains if patience is part of your investment strategy.

    The company has other thing cooking that at this time are not finalized and if finalized could growth the company even quicker than has been exhibited during the past 3 years.

    Profits can be reached as revenue spikes, but with the cost of doing business and the ability to keep their prized employees a certain level of revenue must be reached.

    Bottom line I think Hemacare will reward handsomely, but you must be patient and corporate surprised can happen at any time. They continue to go to conference and this will continue to expose potential investor's and additional big pharma and biotech's to flock to buying their productions.

    Lastly a few months ago they mention logistic venture was put in place-so everything is in place and the puzzle is looking better and better it is just a matter of time.